
The road from #EvidenceToAction continues in your labs and clinics as you accelerate GBS prevention in a changing world.

Identifying and preventing morbidity and mortality caused by Group B Strep disease. Global Conference ISSAD #GroupBStrep #Meningitis #ISSAD2026 #Streptococcus

The road from #EvidenceToAction continues in your labs and clinics as you accelerate GBS prevention in a changing world.

Now that our #ISSAD2026 delegates are back home and settled into their routines, we want to say a huge THANK YOU for making the 4th International Symposium on Streptoccocus agalactiae disease so impactful. #GBS #ISSAD2026

Highlights | MU-JHU at ISSAD 2026 MU-JHU proudly showcased its growing Group B Streptococcus research portfolio at the @IssadOrg 2026 Conference. Data Manager Valeria Tusubira presented a poster titled “Risk Factors of Vertical Transmission of Group B Streptococcus Among Colonised Mothers in Kampala, Uganda.” We also celebrate our wider research team whose poster presentations strengthened the scientific dialogue: Dr. Agnes Ssali, Ritah Namugumya, Zam Nabalwanyi, Agnes Nyamaizi, Gordon Rukundo and Phiona Nalubega. The meeting further featured MU-JHU expertise in Intrapartum Antibiotic Prophylaxis (IAP) for GBS Prevention during Plenary 6 chaired by Dr. Eve Nakabembe and Prof. Kirsty Le Doare. Many thanks to the team for representing MU-JHU with excellence and commitment to improving maternal and newborn health. For more information, visit: issad.org/issad-2026-confere…

Day 2’s sessions shifted the focus to the GBS vaccine pipeline and the complex policy frameworks required to ensure global access. The energy among our 37-country delegation remained high as we moved into the final day of the symposium!🔬 #ISSAD2026 #PublicHealth

The PS underscored the government's commitment to integrate GBS prevention into public health frameworks & praised the collective efforts of researchers and scientists present. A call to action for all of us to ensure every newborn has a healthy start, regardless of geography.

"Collaboration is the bridge between policy & impact." We were honoured to host Ms MARY MUTHONI, CBS, HSC., Principal Secretary in the State Department for Public Health (@MOH_Kenya), at our gala dinner. @KEMRI_Kenya


Plenary 5 at #ISSAD2026 has taken us From Evidence to Action, moving beyond the lab to talk about how we actually reach the mothers & babies who need these vaccines most. Because a vaccine only works if it's accessible, sustainable, & safe for everyone. #ISSAD #GlobalHealth


The science of GBS vaccines is advancing rapidly, but how do we implement them? In Plenary 4, we look at the evidence and economics behind the rollout. #ISSAD2026 #GBS #GlobalHealth



Plenary 3 at #ISSAD2026 has the architects of the next generation of maternal immunisation. From the lab bench to phase trials, this is where the future of neonatal protection is being written. #ISSAD2026 #VaccineDevelopment #GBS #GlobalHealth



Not all impacts of GBS are easily captured in standard surveillance. Today at #ISSAD2026, Plenary 2 dove into the "incomplete narratives" of GBS, from stillbirths to preterm births and the burden on non-pregnant adults in LMICs. #ISSAD2026 #PublicHealth #GlobalHealth